The rising prevalence of cancer, cardiovascular diseases, and neurological diseases is expected to play a pivotal role in the growth of the resveratrol market in the coming years.Dallas, Texas, Jan. 26, 2021 (GLOBE NEWSWIRE) — The global resveratrol market is growing at a CAGR of 7.9% by 2028. An increase in prevalence of chronic disorders, surge in resveratrol supplements, and wide application areas of resveratrol are factors driving the global resveratrol market. Adroit Market Research report on global resveratrol market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 and 2019, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter’s five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global resveratrol market have been studied in detail. Request for a sample of this research report @ https://www.adroitmarketresearch.com/contacts/request-sample/503 Resveratrol is a natural stilbene and a non-flavonoid polyphenol, a phytoestrogen that predominates in antioxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. It occurs naturally in many plants, such as grapes, and berries, and aids in assistance with respect to pathogenic infections. The first of its kind resveratrol was extracted from the root of a fast-growing shrub called the Japanese knotweed. Resveratrol is known to reverse multidrug resistance in cancer cells and is used in combination with drugs. Rapid rise in chronic ailments such as cancer, cardiac diseases, and neurological disorders will augment the demand for resveratrol products and supplements. However, side effects like gastrointestinal upset, headache, nausea and fatigue associated with resveratrol usage will hamper the growth of the market in the future. The global resveratrol market has been segmented based on product, application, form, distribution channel, and region. Based on product, the global resveratrol market is categorized into natural and synthetic resveratrol. Natural resveratrol segment is further sub-divided into grape seed extracted and knotweed extracted. Application-wise, the global resveratrol market is categorized into cosmetics, pharmaceuticals, dietary supplements and others. Cosmetics segment held substantial share of the market in 2019 owing to increase use of resveratrol in cosmetics owing to its anti-aging properties. Based on form, the global resveratrol market is classified as liquid, solid/powder and pill. Liquid resveratrol segment dominated the global market in 2019 owing to its ability to get quickly absorbed by the body and act as a free radical scavenger. The liquid form of resveratrol has naturally occurring proanthocyanidins (OPCs) from grape seed extract, VitaBerry, cranberry, and pomegranate, which complement resveratrol’s cellular and cardiovascular support properties. On the basis of distribution channel, the global resveratrol market is segmented into retail stores, online stores and others. Browse Complete Report with Table of Contents @ https://www.adroitmarketresearch.com/industry-reports/resveratrol-market North America dominated the global resveratrol market in 2019. High consumption of resveratrol supplements owing to its protective benefits for several health conditions across U.S. and Canada is a major factor for its dominant share. Asia Pacific is estimated to be the most lucrative market for resveratrol during the forecast period and is expected to grow at a faster pace from 2020 to 2028. Increasing demand from countries such as India and China and increasing awareness regarding the health benefits of resveratrol and high consumption in Asian countries such as Japan and China, as a traditional herbal remedy will drive the market in the region. Major players operating in the global resveratrol market include DSM, Evolva, Jeunesse Global, RevGenetics, Sabinsa Corporation, Maypro Industries, Hangzhou Great Forest Biomedical Ltd., Laurus Labs, Tianjin Jianfeng Natural Product R&D Co., Ltd., and Shanghai Natural Bio-engineering Co., Ltd. (Hunan Keyuan Bio-products Co., Ltd) among others. Based on segmentation global resveratrol market is fragmented into product, application, form, distribution channel and regional industry. By product, global resveratrol market is splintered into natural resveratrol, grape seed extracted, knotweed extracted & synthetic resveratrol. Based on application the market is classified into dietary supplements, cosmetics, pharmaceutical & others. Based on form the market is classified into liquid, solid/powder, pill. In terms of distribution channel, resveratrol market is segregated into retail stores, online stores & others. Further, resveratrol market is also fragmented on the basis of regional diversification, identifying Europe, North and South America, MEA and APAC as major growth spots in data science platform market. Direct purchase the report @ https://www.adroitmarketresearch.com/researchreport/purchase/503 Table of Content: 1. Introduction 2. Research Methodology 3. Market Outlook 4. Resveratrol Market by Product, 2018-2028 (USD Million) 5. Resveratrol Market by Application, 2018-2028 (USD Million) 6. Resveratrol Market by Form, 2018-2028 (USD Million) 7. Resveratrol Market by Distribution Channel, 2018-2028 (USD Million) 8. Resveratrol Market by Region, 2018-2028 (USD Million) 9. Company Profiles Browse Related Reports: Global Thoracic Drainage Devices Market Size 2019, by Product (Thoracic Drainage Systems, Thoracic Drainage Kits, Pleural Drainage Catheters, Trocar Drains, Others), by Application (Cardiac Surgery, Oncology & Pain Management, Thoracic Surgery & Pulmonology, General Intensive Care Emergency Medicine, Others), by Region and Forecast 2018 to 2028 Global Wound Debridement Market Size 2019, by Product (Gels, Ointment & creams, Surgical devices, Medical gauzes, Ultrasonic devices, Others), by Method (Autolytic, Enzymatic, Surgical, Mechanical, Others), by Wound Type (Pressure ulcers, Diabetic foot ulcers, Venous leg ulcers, Burn wound, Others), by Region and Forecast 2018 to 2028 Global Sternal Closure Systems Market Size 2020, By Product (Closure Devices, Bone Cement) Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy) Material (Stainless Steel, PEEK, Titanium) Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) and Forecast 2021 to 2028 Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html About Us: Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Contact Us: Ryan Johnson Account Manager – Global 3131 McKinney Ave Ste 600 Dallas, TX 75204 Email ID: sales@adroitmarketresearch.com Phone No.: +1 972-362 -8199 Connect with us: Facebook | Twitter | LinkedIn
Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.
Here’s a timeline of key events in the bread price-fixing case.
Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.
Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.
Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.
Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).
Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.
June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.
Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”
Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.
July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.
Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.
This report by The Canadian Press was first published Sept. 19, 2024.
Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)
TORONTO – Canada’s main stock index was up more than 250 points in late-morning trading, led by strength in the base metal and technology sectors, while U.S. stock markets also charged higher.
The S&P/TSX composite index was up 254.62 points at 23,847.22.
In New York, the Dow Jones industrial average was up 432.77 points at 41,935.87. The S&P 500 index was up 96.38 points at 5,714.64, while the Nasdaq composite was up 486.12 points at 18,059.42.
The Canadian dollar traded for 73.68 cents US compared with 73.58 cents US on Thursday.
The November crude oil contract was up 89 cents at US$70.77 per barrel and the October natural gas contract was down a penny at US2.27 per mmBTU.
The December gold contract was up US$9.40 at US$2,608.00 an ounce and the December copper contract was up four cents at US$4.33 a pound.
This report by The Canadian Press was first published Sept. 19, 2024.
VANCOUVER – Supervised injection sites are saving the lives of drug users everyday, but the same support is not being offered to people who inhale illicit drugs, the head of the BC Centre for Excellence in HIV/AIDS says.
Dr. Julio Montaner said the construction of Vancouver’s first indoor supervised site for people who inhale drugs comes as the percentage of people who die from smoking drugs continues to climb.
The location in the Downtown Eastside at the Hope to Health Research and Innovation Centre was unveiled Wednesday after construction was complete, and Montaner said people could start using the specialized rooms in a matter of weeks after final approvals from the city and federal government.
“If we don’t create mechanisms for these individuals to be able to use safely and engage with the medical system, and generate points of entry into the medical system, we will never be able to solve the problem,” he said.
“Now, I’m not here to tell you that we will fix it tomorrow, but denying it or ignoring it, or throw it under the bus, or under the carpet is no way to fix it, so we need to take proactive action.”
Nearly two-thirds of overdose deaths in British Columbia in 2023 came after smoking illicit drugs, yet only 40 per cent of supervised consumption sites in the province offer a safe place to smoke, often outdoors, in a tent.
The centre has been running a supervised injection site for years which sees more than a thousand people monthly and last month resuscitated five people who were overdosing.
The new facilities offer indoor, individual, negative-pressure rooms that allow fresh air to circulate and can clear out smoke in 30 to 60 seconds while users are monitored by trained nurses.
Advocates calling for more supervised inhalation sites have previously said the rules for setting up sites are overly complicated at a time when the province is facing an overdose crisis.
More than 15,000 people have died of overdoses since the public health emergency was declared in B.C. in April 2016.
Kate Salters, a senior researcher at the centre, said they worked with mechanical and chemical engineers to make sure the site is up to code and abidies by the highest standard of occupational health and safety.
“This is just another tool in our tool box to make sure that we’re offering life-saving services to those who are using drugs,” she said.
Montaner acknowledged the process to get the site up and running took “an inordinate amount of time,” but said the centre worked hard to follow all regulations.
“We feel that doing this right, with appropriate scientific background, in a medically supervised environment, etc, etc, allows us to derive the data that ultimately will be sufficiently convincing for not just our leaders, but also the leaders across the country and across the world, to embrace the strategies that we are trying to develop.” he said.
Montaner said building the facility was possible thanks to a single $4-million donation from a longtime supporter.
Construction finished with less than a week before the launch of the next provincial election campaign and within a year of the next federal election.
Montaner said he is concerned about “some of the things that have been said publicly by some of the political leaders in the province and in the country.”
“We want to bring awareness to the people that this is a serious undertaking. This is a very massive investment, and we need to protect it for the benefit of people who are unfortunately drug dependent.” he said.
This report by The Canadian Press was first published Sept. 18, 2024.
